Women Undergoing Hormonal Treatments for Infertility: A Systematic Review on Psychopathology and Newly Diagnosed Mood and Psychotic Disorders.
affective
fertility treatments
infertility
psychosis
sex hormones
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2020
2020
Historique:
received:
11
03
2020
accepted:
11
05
2020
entrez:
13
6
2020
pubmed:
13
6
2020
medline:
13
6
2020
Statut:
epublish
Résumé
The association between infertility treatments and mental disorders has been poorly addressed. This work aims to review current evidence on the psychopathological effects of hormonal treatments used for infertility on women and the occurrence of newly diagnosed mood and psychotic disorders. A systematic review was performed by searching PubMed and clinicaltrials.gov databases from inception until September 2019. Clinical trials on hormone treatments for infertility in patients with mood or psychotic disorders, as well as those evaluating the onset of symptoms, were included. Selected studies were published in English, Spanish, and Dutch language peer-reviewed journals. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Observational studies and case reports were excluded. Effect sizes for changes in depressive symptoms were calculated with Hedges'g and Cohen's d confidence intervals. A meta-analysis was not performed due to the heterogeneity of hormonal compounds in protocols. From 1,281 retrieved records, nine trials were included; all of them were conducted in non-clinical populations. Four trials compared Gonadotropin-releasing hormone (GnRH) agonists and GnRH antagonists, showing a better mood profile for hormonal protocols including antagonists in one trial. Two trials compared protocols using GnRH agonists/antagonists versus natural cycle protocols (without gonadotropin stimulation), with a better mood profile (less depressive symptoms) in those protocols without gonadotropin stimulation. Other studies compared long and short protocols of GnRH agonists (no differences); two GnRH agonists, buserelin, and goserelin (no differences); and two patterns of clomiphene vs placebo administration (no differences). None of the selected studies investigated the risk of relapse in women with a previous diagnosis of depressive or psychotic disorders. When exploring pre-post changes in depressive symptoms, effect sizes suggested mild mood worsenings for most protocols (effect sizes ≤ -0.4), with the following pattern (worse to better): GnRH agonist > GnRH antagonist > no gonadotropin stimulation. This is the first systematic review exploring the psychopathological effects of hormonal infertility treatments. Our study suggests that protocols without gonadotropin stimulation show a better mood profile when compared to those using GnRH antagonists or GnRH agonists. Future studies need to include patients with major mood and psychotic disorders.
Sections du résumé
BACKGROUND
BACKGROUND
The association between infertility treatments and mental disorders has been poorly addressed. This work aims to review current evidence on the psychopathological effects of hormonal treatments used for infertility on women and the occurrence of newly diagnosed mood and psychotic disorders.
METHODS
METHODS
A systematic review was performed by searching PubMed and clinicaltrials.gov databases from inception until September 2019. Clinical trials on hormone treatments for infertility in patients with mood or psychotic disorders, as well as those evaluating the onset of symptoms, were included. Selected studies were published in English, Spanish, and Dutch language peer-reviewed journals. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Observational studies and case reports were excluded. Effect sizes for changes in depressive symptoms were calculated with Hedges'g and Cohen's d confidence intervals. A meta-analysis was not performed due to the heterogeneity of hormonal compounds in protocols.
RESULTS
RESULTS
From 1,281 retrieved records, nine trials were included; all of them were conducted in non-clinical populations. Four trials compared Gonadotropin-releasing hormone (GnRH) agonists and GnRH antagonists, showing a better mood profile for hormonal protocols including antagonists in one trial. Two trials compared protocols using GnRH agonists/antagonists versus natural cycle protocols (without gonadotropin stimulation), with a better mood profile (less depressive symptoms) in those protocols without gonadotropin stimulation. Other studies compared long and short protocols of GnRH agonists (no differences); two GnRH agonists, buserelin, and goserelin (no differences); and two patterns of clomiphene vs placebo administration (no differences). None of the selected studies investigated the risk of relapse in women with a previous diagnosis of depressive or psychotic disorders. When exploring pre-post changes in depressive symptoms, effect sizes suggested mild mood worsenings for most protocols (effect sizes ≤ -0.4), with the following pattern (worse to better): GnRH agonist > GnRH antagonist > no gonadotropin stimulation.
CONCLUSIONS
CONCLUSIONS
This is the first systematic review exploring the psychopathological effects of hormonal infertility treatments. Our study suggests that protocols without gonadotropin stimulation show a better mood profile when compared to those using GnRH antagonists or GnRH agonists. Future studies need to include patients with major mood and psychotic disorders.
Identifiants
pubmed: 32528332
doi: 10.3389/fpsyt.2020.00479
pmc: PMC7264258
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
479Informations de copyright
Copyright © 2020 González-Rodríguez, Cobo, Soria, Usall, Garcia-Rizo, Bioque, Monreal and Labad.
Références
Int J Clin Exp Pathol. 2013 Aug 15;6(9):1903-10
pubmed: 24040457
J Obstet Gynecol Neonatal Nurs. 1991 Jul-Aug;20(4):321-7
pubmed: 1941294
Psychoneuroendocrinology. 2018 Jul;93:8-19
pubmed: 29680774
Biol Psychiatry. 1998 Mar 15;43(6):464-5
pubmed: 9532352
J Psychiatry Neurosci. 2008 Jul;33(4):331-43
pubmed: 18592034
Hum Reprod. 2008 Sep;23(9):2056-63
pubmed: 18583334
Lancet. 2007 Mar 3;369(9563):743-749
pubmed: 17336650
Hum Reprod. 2020 Feb 29;35(2):446-452
pubmed: 32020190
Acta Obstet Gynecol Scand. 2018 Mar;97(3):269-276
pubmed: 29247514
Hum Reprod. 2016 Jun;31(6):1253-64
pubmed: 27060174
Fertil Steril. 2015 May;103(5):1332-9
pubmed: 25796319
Hum Reprod. 2013 Apr;28(4):1100-9
pubmed: 23300199
Psychopharmacol Bull. 1997;33(2):311-6
pubmed: 9230649
Eur J Obstet Gynecol Reprod Biol. 2014 Jun;177:115-20
pubmed: 24721442
J Womens Health (Larchmt). 2018 Nov;27(11):1408-1414
pubmed: 30067141
J Med Life. 2015 Apr-Jun;8(2):129-31
pubmed: 25866566
J Hum Reprod Sci. 2015 Apr-Jun;8(2):86-92
pubmed: 26157299
Obstet Gynecol Clin North Am. 2018 Sep;45(3):563-574
pubmed: 30092929
Hum Reprod. 2019 Nov 1;34(11):2173-2183
pubmed: 31725877
Reprod Biomed Online. 2012 Jun;24(6):591-602
pubmed: 22503948
BMC Psychiatry. 2005 Dec 14;5:46
pubmed: 16351733
Lancet Psychiatry. 2017 Jan;4(1):63-72
pubmed: 27856396
J Assist Reprod Genet. 2016 Jul;33(7):873-84
pubmed: 27221477
Depress Anxiety. 1998;7(4):171-7
pubmed: 9706454
Fertil Steril. 2018 May;109(5):879-887
pubmed: 29778387
Aust N Z J Psychiatry. 2016 Dec;50(12):1207-1208
pubmed: 27207861
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Fertil Steril. 2018 May;109(5):888-899
pubmed: 29778388
Psychiatr Clin North Am. 2010 Jun;33(2):309-21
pubmed: 20385339
Arch Ophthalmol. 1995 Apr;113(4):482-4
pubmed: 7710399
Psychiatr Pol. 2015;49(5):965-82
pubmed: 26688847
J Assist Reprod Genet. 2017 Feb;34(2):167-177
pubmed: 27817040
Fertil Steril. 2011 Jan;95(1):307-9
pubmed: 20801439
Eur Psychiatry. 2017 Sep;45:212-219
pubmed: 28957789
Fertil Steril. 2018 Jul 1;110(1):4
pubmed: 29980260
Neuropsychopharmacology. 2019 Jan;44(1):111-128
pubmed: 30061743
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Curr Drug Saf. 2017;12(3):208-215
pubmed: 28625145
Hum Reprod. 2007 Sep;22(9):2554-8
pubmed: 17586832
J Psychosom Obstet Gynaecol. 2005 Jun;26(2):93-100
pubmed: 16050534
Schizophr Res. 2020 Aug;222:88-96
pubmed: 32507371
Gynecol Endocrinol. 2015 Oct;31(10):751-4
pubmed: 26291819
Dialogues Clin Neurosci. 2018 Mar;20(1):41-47
pubmed: 29946210
Psychiatry Res. 2015 Jun 30;232(3):226-36
pubmed: 25914141
Dialogues Clin Neurosci. 2011;13(1):109-25
pubmed: 21485751
J Med Case Rep. 2017 Mar 6;11(1):60
pubmed: 28260524
Front Endocrinol (Lausanne). 2019 Jul 03;10:429
pubmed: 31333582
J Reprod Infant Psychol. 2017 Feb;35(1):1-13
pubmed: 29517288
Hum Reprod. 2015 Jan;30(1):103-10
pubmed: 25398970
Nervenarzt. 2007 Jun;78(6):691-2, 694-5
pubmed: 17487467
Psychosomatics. 2015 Sep-Oct;56(5):598-602
pubmed: 26362915
Am J Psychiatry. 2013 Apr;170(4):426-33
pubmed: 23545794
Hum Reprod. 1993 Dec;8(12):2052-5
pubmed: 8150902